Smith, Moore & Co. »

Aardvark Therapeutics shares owned by Smith, Moore & Co.

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Smith, Moore & Co. from 13F filings

Historical chart of Smith, Moore & Co. investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Smith, Moore & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Smith, Moore & Co.

Quarter filed Position value Share count Share price at filing
2026-06-30 $115k 20k 5.76

More positions owned by Smith, Moore & Co.

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares S&p 500 Value Etf Etf (IVE)
Bondbloxx Bloomberg One Year Target Duration Us Treasury Etf Etf (XONE)
State Street Spdr S&p Midcap 400 Etf Trust Etf (MDY)
Apple Stock (AAPL)
Ishares Russell 1000 Growth Etf Etf (IWF)
State Street Spdr S&p 500 Etf Etf (SPY)
Ishares Core S&p Small Cap Etf Etf (IJR)
Invesco Qqq Trust Series I Etf (QQQ)
Capital Group Dividend Value Etf Etf (CGDV)
Fundstrat Granny Shots Us Large Cap Etf Etf (GRNY)
Vanguard Dividend Appreciation Etf Etf (VIG)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Vanguard Ftse Developed Markets Etf Etf (VEA)

View all positions for Smith, Moore & Co.

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
Vanguard Capital Management
AQR Capital Management
EcoR1 Capital
Adage Capital Partners GP
State Street Corporation
BlackRock
Geode Capital Management
Cantor Fitzgerald, L. P.
Two Sigma Investments
Raymond James Financial
Vanguard Fiduciary Trust
Woodline Partners

View all funds holding Aardvark Therapeutics